Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | SETDB1 | Q15047 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2922219 | 0.99 | MAPT (0.31) | MAPTKDM4EALDH1A1HSD17B10SETDB1 | |
| SCHEMBL2923760 | 0.93 | L3MBTL1 (0.36) | MAPTSETDB1L3MBTL1HRH3 | |
| SCHEMBL2916046 | 0.92 | L3MBTL1 (0.34) | MAPTSETDB1L3MBTL1 | |
| SCHEMBL2923913 | 0.91 | MAPT (0.31) | MAPTSETDB1HRH3 | |
| SCHEMBL2921799 | 0.90 | LMNA (0.33) | MAPTKDM4EALDH1A1SETDB1 | |
| SCHEMBL2915859 | 0.90 | SETDB1 (0.31) | SETDB1 | |
| SCHEMBL2922696 | 0.90 | MAPT (0.31) | MAPTHRH3 | |
| SCHEMBL2922482 | 0.89 | SETDB1 (0.32) | MAPTSETDB1 | |
| SCHEMBL2924295 | 0.89 | CYP3A4 (0.31) | MAPT | |
| SCHEMBL2913420 | 0.85 | CXCR5 (0.34) | MAPTALDH1A1SETDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1475383-B1 | TRANSITION METAL COMPLEXES, LIGANDS, POLYMERIZATION CATALYSTS FOR OLEFINS, AND PROCESS FOR PRODUCTION OF OLEFIN POLYMERS | SUMITOMO CHEMICAL CO (JP) | 2010-09-08 | — | — | EP | disclosed |
| US-7241927-B2 | Transition metal complexes, ligands, catalysts for olefin polymerization, and process for production of olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-07-10 | — | — | US | disclosed |
| US-7141690-B2 | Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-11-28 | — | — | US | disclosed |
| US-20060111525-A1 | Transition metal complexes, ligands, catalysts for olefin polymerization, and process for production of olefin polymers | HANAOKA HIDENORI | 2006-05-25 | — | — | US | disclosed |
| US-20050154158-A1 | Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-14 | — | — | US | disclosed |
| EP-1475383-A1 | TRANSITION METAL COMPLEXES, LIGANDS, POLYMERIZATION CATALYSTS FOR OLEFINS, AND PROCESS FOR PRODUCTION OF OLEFIN POLYMERS | Sumitomo Chemical Company, Limited (JP) | 2004-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154158-A1 | Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers | PYM1, OR10J3, AP1M1 | MAPT 3972/4885KDM4E 3424/4885ALDH1A1 2570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.